C, B., H, F., VM, R., MJ, H., O, I., L, A., . . . D, K. (2026). Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study. Cancers, 18(2), . https://doi.org/10.3390/cancers18020278
Chicago Style (17th ed.) CitationC, Braschel, et al. "Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study." Cancers 18, no. 2 (2026). https://doi.org/10.3390/cancers18020278.
MLA (9th ed.) CitationC, Braschel, et al. "Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study." Cancers, vol. 18, no. 2, 2026, https://doi.org/10.3390/cancers18020278.